Table 1 Characteristics of eligible studies considered in the meta-analysis
Ethnicity | First author (year) | Single-nucleotide polymorphism | Case no. | Control no. | Diagnostic standard |
|---|---|---|---|---|---|
Asian | Misonoa (2009)7 | A46G | 194 | 208 | SBP⩾140, DBP⩾90 |
Asian | Yu (2008)9 | A46G, C79G | 58 | 58 | SBP⩾140, DBP⩾90 |
Asian | Mo (2007)11 | C79G | 288 | 149 | SBP⩾140, DBP⩾90 |
Asian | Wu CHN-Hani (2006)5 | A46G, C79G | 172 | 133 | SBP⩾140, DBP⩾90 |
Asian | Wu CHN-Yi (2006)5 | A46G, C79G | 99 | 134 | SBP⩾140, DBP⩾90 |
Asian | Ge (2005)10 | C79G | 503 | 504 | SBP⩾160, DBP⩾100 |
Asian | Kato (2001)16 | A46G, C79G | 1141 | 852 | SBP⩾160, DBP⩾95 |
Caucasian | Gjesing (2007)20 | A46G, C79G | 2511 | 3984 | SBP⩾140, DBP⩾90 |
Caucasian | Bartels (2007)15 | A46G, C79G | 258 | 171 | SBP⩾140, DBP⩾90 |
Caucasian | Pojoga (2006)6 | A46G, C79G | 280 | 65 | DBP⩾90 (with treatment) or DBP⩾100 |
Caucasian | Filigheddu (2004)4 | A46G | 517 | 184 | SBP⩾140, DBP⩾90 |
Caucasian | Castellano (2003)8 | A46G, C79G | 324 | 247 | SBP⩾140, DBP⩾90 |
Caucasian | Sunder-Plassmann (2002)13 | A46G, C79G | 182 | 182 | DBP⩾120 |
Caucasian | Herrmann SM (2002)17 | A46G, C79G | 707 | 290 | DBP⩾100 |
Caucasian | Herrmann V (2000)18 | A46G | 36 | 101 | SBP⩾140, DBP⩾95 |
Caucasian | Xie (2000)14 | A46G, C79G | 201 | 179 | SBP⩾140, DBP⩾90 |
Caucasian | Jia (2000)19 | C79G | 298 | 298 | SBP⩾160, DBP⩾90 |
Mixed African | Tang (2003)27 | A46G | 134 | 143 | SBP⩾160, DBP⩾100 |
Mixed African | Xie (2000)14 | A46G, C79G | 155 | 128 | SBP⩾140, DBP⩾90 |
Mixed African | Candy (2000)12 | A46G, C79G | 192 | 123 | DBP⩾90 |
